Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CorMedix (CRMD) Accumulated Expenses (2016 - 2025)

CorMedix (CRMD) has disclosed Accumulated Expenses for 13 consecutive years, with $2.3 million as the latest value for Q4 2025.

  • Quarterly Accumulated Expenses fell 92.7% to $2.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.3 million through Dec 2025, down 92.7% year-over-year, with the annual reading at $2.3 million for FY2025, 92.7% down from the prior year.
  • Accumulated Expenses hit $2.3 million in Q4 2025 for CorMedix, down from $109.1 million in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $109.1 million in Q3 2025 to a low of $1.0 million in Q1 2021.
  • Historically, Accumulated Expenses has averaged $11.5 million across 5 years, with a median of $3.6 million in 2025.
  • Biggest YoY gain for Accumulated Expenses was 2178.19% in 2025; the steepest drop was 92.7% in 2025.
  • Year by year, Accumulated Expenses stood at $3.0 million in 2021, then surged by 31.84% to $4.0 million in 2022, then grew by 29.3% to $5.1 million in 2023, then surged by 521.85% to $32.0 million in 2024, then plummeted by 92.7% to $2.3 million in 2025.
  • Business Quant data shows Accumulated Expenses for CRMD at $2.3 million in Q4 2025, $109.1 million in Q3 2025, and $3.6 million in Q2 2025.